Lymph Node Dissection in Testicular Cancer: The State of the Art and Future Perspectives.

IF 4.7 2区医学 Q1 ONCOLOGY Current Oncology Reports Pub Date : 2024-04-01 Epub Date: 2024-03-02 DOI:10.1007/s11912-024-01511-y

Bartosz Małkiewicz, Gabriela Świrkosz, Wojciech Lewandowski, Katarzyna Demska, Zuzanna Szczepaniak, Jakub Karwacki, Wojciech Krajewski, Tomasz Szydełko

{"title":"Lymph Node Dissection in Testicular Cancer: The State of the Art and Future Perspectives.","authors":"Bartosz Małkiewicz, Gabriela Świrkosz, Wojciech Lewandowski, Katarzyna Demska, Zuzanna Szczepaniak, Jakub Karwacki, Wojciech Krajewski, Tomasz Szydełko","doi":"10.1007/s11912-024-01511-y","DOIUrl":null,"url":null,"abstract":"Purpose of review: This narrative review provides a comprehensive overview of the evolving role of retroperitoneal lymph node dissection (RPLND) in the management of testicular cancer (TC). It explores the significance of RPLND as both a diagnostic and therapeutic tool, highlighting its contribution to accurate staging, its impact on oncological outcomes, and its influence on subsequent treatment decisions.Recent findings: RPLND serves as an essential diagnostic procedure, aiding in the precise assessment of lymph node involvement and guiding personalized treatment strategies. It has demonstrated therapeutic value, particularly in patients with specific risk factors and disease stages, contributing to improved oncological outcomes and survival rates. Recent studies have emphasized the importance of meticulous patient selection and nerve-sparing techniques to mitigate complications while optimizing outcomes. Additionally, modern imaging and surgical approaches have expanded the potential applications of RPLND. In the context of TC management, RPLND remains a valuable and evolving tool. Its dual role in staging and therapy underscores its relevance in contemporary urological practice. This review highlights the critical role of RPLND in enhancing patient care and shaping treatment strategies, emphasizing the need for further research to refine patient selection and surgical techniques.","PeriodicalId":10861,"journal":{"name":"Current Oncology Reports","volume":null,"pages":null},"PeriodicalIF":4.7000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11021343/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Oncology Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11912-024-01511-y","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/2 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of review: This narrative review provides a comprehensive overview of the evolving role of retroperitoneal lymph node dissection (RPLND) in the management of testicular cancer (TC). It explores the significance of RPLND as both a diagnostic and therapeutic tool, highlighting its contribution to accurate staging, its impact on oncological outcomes, and its influence on subsequent treatment decisions.

Recent findings: RPLND serves as an essential diagnostic procedure, aiding in the precise assessment of lymph node involvement and guiding personalized treatment strategies. It has demonstrated therapeutic value, particularly in patients with specific risk factors and disease stages, contributing to improved oncological outcomes and survival rates. Recent studies have emphasized the importance of meticulous patient selection and nerve-sparing techniques to mitigate complications while optimizing outcomes. Additionally, modern imaging and surgical approaches have expanded the potential applications of RPLND. In the context of TC management, RPLND remains a valuable and evolving tool. Its dual role in staging and therapy underscores its relevance in contemporary urological practice. This review highlights the critical role of RPLND in enhancing patient care and shaping treatment strategies, emphasizing the need for further research to refine patient selection and surgical techniques.

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

睾丸癌淋巴结清扫术：技术现状与未来展望》。

综述目的：这篇叙述性综述全面概述了腹膜后淋巴结清扫术（RPLND）在睾丸癌（TC）治疗中不断发展的作用。它探讨了 RPLND 作为诊断和治疗工具的意义，强调了它对准确分期的贡献、对肿瘤治疗结果的影响以及对后续治疗决策的影响：RPLND是一项重要的诊断程序，有助于精确评估淋巴结受累情况并指导个性化治疗策略。它已被证明具有治疗价值，尤其是对具有特定风险因素和疾病分期的患者，有助于改善肿瘤治疗效果和提高生存率。最近的研究强调了精心选择患者和保留神经技术的重要性，以便在优化疗效的同时减少并发症。此外，现代成像和手术方法也扩大了 RPLND 的潜在应用范围。在TC管理方面，RPLND仍然是一种有价值且不断发展的工具。它在分期和治疗中的双重作用凸显了其在当代泌尿外科实践中的重要性。本综述强调了 RPLND 在加强患者护理和制定治疗策略方面的关键作用，同时强调了进一步研究完善患者选择和手术技术的必要性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Current Oncology Reports ONCOLOGY-

CiteScore

8.50

自引率

0.00%

发文量

187

审稿时长

6-12 weeks

期刊介绍： This journal aims to review the most important, recently published clinical findings in the field of oncology. By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care of those affected by cancer. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as cancer prevention, leukemia, melanoma, neuro-oncology, and palliative medicine. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.